Sort by
Items per page

Send to

Choose Destination

Best matches for natural immunosuppression AND septicemia AND systemic infection AND therapeutic immunosuppression:

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Hotchkiss RS et al. Nat Rev Immunol. (2013)

Immunopathogenesis of abdominal sepsis. Weber GF et al. Langenbecks Arch Surg. (2014)

The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Boomer JS et al. Virulence. (2014)

Search results

Items: 1 to 20 of 294


Polymicrobial sepsis and non-specific immunization induce adaptive immunosuppression to a similar degree.

Schmoeckel K, Mrochen DM, Hühn J, Pötschke C, Bröker BM.

PLoS One. 2018 Feb 7;13(2):e0192197. doi: 10.1371/journal.pone.0192197. eCollection 2018.


Betacaryophyllene - A phytocannabinoid as potential therapeutic modality for human sepsis?

Meza A, Lehmann C.

Med Hypotheses. 2018 Jan;110:68-70. doi: 10.1016/j.mehy.2017.10.025. Epub 2017 Nov 4.


Proteomic changes of CD4+/CD25+/forkhead box p3+ regulatory T cells in a 30-day rat model of sepsis survival.

Jiao Y, Tan S, Xiong J.

Exp Ther Med. 2017 Dec;14(6):5619-5628. doi: 10.3892/etm.2017.5233. Epub 2017 Sep 29.


Potential Immunotherapeutics for Immunosuppression in Sepsis.

Shin J, Jin M.

Biomol Ther (Seoul). 2017 Nov 1;25(6):569-577. doi: 10.4062/biomolther.2017.193. Review.


Expression of C/EBPβ in myeloid progenitors during sepsis promotes immunosuppression.

Dai J, Kumbhare A, Youssef D, Yao ZQ, McCall CE, El Gazzar M.

Mol Immunol. 2017 Nov;91:165-172. doi: 10.1016/j.molimm.2017.09.008. Epub 2017 Sep 19.


Immune disorders in sepsis and their treatment as a significant problem of modern intensive care.

Łysenko L, Leśnik P, Nelke K, Gerber H.

Postepy Hig Med Dosw (Online). 2017 Aug 22;71(1):703-712.


Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4.

Kurup SP, Obeng-Adjei N, Anthony SM, Traore B, Doumbo OK, Butler NS, Crompton PD, Harty JT.

Nat Med. 2017 Oct;23(10):1220-1225. doi: 10.1038/nm.4395. Epub 2017 Sep 11.


A Murine Model of Persistent Inflammation, Immune Suppression, and Catabolism Syndrome.

Pugh AM, Auteri NJ, Goetzman HS, Caldwell CC, Nomellini V.

Int J Mol Sci. 2017 Aug 10;18(8). pii: E1741. doi: 10.3390/ijms18081741.


Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression?

Winkler MS, Rissiek A, Priefler M, Schwedhelm E, Robbe L, Bauer A, Zahrte C, Zoellner C, Kluge S, Nierhaus A.

PLoS One. 2017 Aug 3;12(8):e0182427. doi: 10.1371/journal.pone.0182427. eCollection 2017.


Sepsis and Critical Illness Research Center investigators: protocols and standard operating procedures for a prospective cohort study of sepsis in critically ill surgical patients.

Loftus TJ, Mira JC, Ozrazgat-Baslanti T, Ghita GL, Wang Z, Stortz JA, Brumback BA, Bihorac A, Segal MS, Anton SD, Leeuwenburgh C, Mohr AM, Efron PA, Moldawer LL, Moore FA, Brakenridge SC.

BMJ Open. 2017 Aug 1;7(7):e015136. doi: 10.1136/bmjopen-2016-015136.


Understanding Immunosuppression after Sepsis.

Fattahi F, Ward PA.

Immunity. 2017 Jul 18;47(1):3-5. doi: 10.1016/j.immuni.2017.07.007.


Local Modulation of Antigen-Presenting Cell Development after Resolution of Pneumonia Induces Long-Term Susceptibility to Secondary Infections.

Roquilly A, McWilliam HEG, Jacqueline C, Tian Z, Cinotti R, Rimbert M, Wakim L, Caminschi I, Lahoud MH, Belz GT, Kallies A, Mintern JD, Asehnoune K, Villadangos JA.

Immunity. 2017 Jul 18;47(1):135-147.e5. doi: 10.1016/j.immuni.2017.06.021.


The novel α-glucan YCP improves the survival rates and symptoms in septic mice by regulating myeloid-derived suppressor cells.

Liu D, You M, Zhao GF, Li XJ, Song YX, Dou H, Yao WB, Gao XD, Hou YY.

Acta Pharmacol Sin. 2017 Sep;38(9):1269-1281. doi: 10.1038/aps.2017.27. Epub 2017 Jun 26.


The REAnimation Low Immune Status Markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients.

Rol ML, Venet F, Rimmele T, Moucadel V, Cortez P, Quemeneur L, Gardiner D, Griffiths A, Pachot A, Textoris J, Monneret G; REALISM study group.

BMJ Open. 2017 Jun 21;7(6):e015734. doi: 10.1136/bmjopen-2016-015734.


The Role of IFN-β during the Course of Sepsis Progression and Its Therapeutic Potential.

Rackov G, Shokri R, De Mon MÁ, Martínez-A C, Balomenos D.

Front Immunol. 2017 May 8;8:493. doi: 10.3389/fimmu.2017.00493. eCollection 2017. Review.


sPD-L1 Expression is Associated with Immunosuppression and Infectious Complications in Patients with Acute Pancreatitis.

Chen Y, Li M, Liu J, Pan T, Zhou T, Liu Z, Tan R, Wang X, Tian L, Chen E, Qu H.

Scand J Immunol. 2017 Aug;86(2):100-106. doi: 10.1111/sji.12564.


Frontline Science: Myeloid cell-specific deletion of Cebpb decreases sepsis-induced immunosuppression in mice.

McPeak MB, Youssef D, Williams DA, Pritchett CL, Yao ZQ, McCall CE, El Gazzar M.

J Leukoc Biol. 2017 Aug;102(2):191-200. doi: 10.1189/jlb.4HI1216-537R. Epub 2017 May 5. Erratum in: J Leukoc Biol. 2018 Mar;103(3):603.


Neutrophil-to-Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage.

Giede-Jeppe A, Bobinger T, Gerner ST, Sembill JA, Sprügel MI, Beuscher VD, Lücking H, Hoelter P, Kuramatsu JB, Huttner HB.

Cerebrovasc Dis. 2017;44(1-2):26-34. doi: 10.1159/000468996. Epub 2017 Apr 19.


Phenotypic Changes and Impaired Function of Peripheral γδ T Cells in Patients With Sepsis.

Liao XL, Feng T, Zhang JQ, Cao X, Wu QH, Xie ZC, Kang Y, Li H.

Shock. 2017 Sep;48(3):321-328. doi: 10.1097/SHK.0000000000000857.


Grape seed proanthocyanidin extract protects lymphocytes against histone-induced apoptosis.

Chang P, Mo B, Cauvi DM, Yu Y, Guo Z, Zhou J, Huang Q, Yan Q, Chen G, Liu Z.

PeerJ. 2017 Mar 21;5:e3108. doi: 10.7717/peerj.3108. eCollection 2017.

Supplemental Content

Loading ...
Support Center